Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Alpharma’s Flector NSAID Patch Off To A Strong Start, CEO Says

This article was originally published in The Pink Sheet Daily

Executive Summary

First topical NSAID patch garners 3,800 scripts in its first two weeks on the market.

You may also be interested in...



King Makes Play For Alpharma To Build Specialty Pain Franchise

Alpharma declines offer; King expresses hope for amicable resolution.

King Makes Play For Alpharma To Build Specialty Pain Franchise

Alpharma declines offer; King expresses hope for amicable resolution.

Alpharma Submits Embeda Abuse-Deterrent Morphine Capsule To FDA

Company files NDA slightly ahead of potential competitor Remoxy, in development by Pain Therapeutics.

Related Content

Topics

UsernamePublicRestriction

Register

LL1135489

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel